Metered Dose Inhaler Devices Market Size Forecast: Revenue and CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Metered Dose Inhaler Devices Industry Expected To Reach By 2029, Starting From 2025 Levels?

The market for metered dose inhaler devices has experienced robust expansion lately, projecting an increase from its 2024 valuation of \$15.46 billion to \$16.23 billion in 2025, driven by a compound annual growth rate (CAGR) of 5.0%; this historical expansion is primarily linked to the rising incidence of diabetes, heightened consumer needs for these devices, a greater availability of metered dose inhaler devices, sustained demand characteristics for metered dose inhaler devices, and the growing prevalence of COPD.

Projections indicate a robust expansion for the metered dose inhaler device sector over the forthcoming years, with its market valuation anticipated to reach $20.03 billion by 2029, reflecting a cumulative annual growth rate of 5.4%. This upward trajectory during the projected timeframe is largely powered by the escalating worldwide incidence of chronic obstructive pulmonary diseases, the growing numbers of asthma cases, the increasing spread of infectious ailments, the rising occurrence of diabetes, and the greater frequency of respiratory conditions. Key developments poised to shape this period involve progress in technology, the introduction of novel treatment modalities, the granting of regulatory authorizations, the creation of next-generation inhalers, and the greater utilization of digital promotion strategies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20878&type=smp

What Are The Drivers Pushing New Developments In The Metered Dose Inhaler Devices Market?

A surge in the occurrence of chronic obstructive pulmonary diseases is anticipated to fuel expansion within the metered dose inhaler devices sector moving ahead. Chronic obstructive pulmonary disease (COPD), which involves a gradual deterioration of lung function marked by restricted airflow, commonly results from prolonged exposure to noxious agents like tobacco smoke, manifesting as trouble breathing, persistent coughing, and wheezing. The rising incidence of this condition, COPD, is attributable to elements such as tobacco consumption, atmospheric contamination, expanding elderly demographics, and instances where diagnosis or therapy is postponed. Medication delivery straight into the respiratory system is facilitated by metered dose inhaler (MDI) apparatuses for managing COPD, offering rapid symptomatic alleviation and better breathing capacity. To illustrate this trend, projections from the National Institutes of Health, a US regulatory body, indicated in December 2023 that global COPD instances are forecasted to escalate from 532 million cases in 2030, reaching an overall figure of 592 million by 2050. Consequently, the expanding worldwide burden of chronic obstructive pulmonary diseases serves as a primary catalyst for the advancement of the market for metered dose inhaler technologies.

What Are The Primary Types Of Segments Analyzed In The Metered Dose Inhaler Devices Market?

The metered dose inhaler devicesmarket covered in this report is segmented –

1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types

2) By Distribution Channel: Online, Offline

3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications

4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices

2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices

3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices

What Key Innovation Trends Are Fueling Advancements In The Metered Dose Inhaler Devices Market?

Leading participants within the metered dose inhaler devices sector are concentrating efforts on innovating sophisticated products, specifically pressurized metered dose inhalers, aiming to boost how effectively medication is delivered and increase adherence from patients. These pressurized metered-dose inhalers (pMDIs) function as inhalation apparatuses, distributing an exact dosage of medicine as an aerosol propelled by pressurized gas. To illustrate, in July of 2023, the pharmaceutical firm Lupin Limited, based in India, introduced Luforbec 100/6, a pMDI intended for managing asthma in adults and chronic obstructive pulmonary disease (COPD) within the German market; this preparation incorporates beclometasone at 100 µg and formoterol at 6 µg, offering a potent treatment option for individuals needing combined medication substances. Significantly, Luforbec’s cost is roughly 47% below the established reference cost, thereby making it more readily available. Given that approximately 5% of adults in Germany are afflicted with asthma, this market entry highlights Lupin’s dedication to meeting essential health demands and fostering better results for individuals receiving respiratory treatment.

Who Are The Primary Competitors In The Global Metered Dose Inhaler Devices Market?

Major companies operating in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, Iconovo AB

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

Which Geographies Are Emerging As Strong Markets For The Metered Dose Inhaler Devices Industry?

North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Metered Dose Inhaler Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20878&type=smp

Browse Through More Reports Similar to the Global Metered Dose Inhaler Devices Market 2025, By The Business Research Company

Respiratory Inhaler Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report

Dry Powder Inhaler Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

Smart Inhalers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795